Loading clinical trials...
Loading clinical trials...
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion: a Randomized, Double-blinded, Placebo-controlled Trial
This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in threatened abortion. Half of participants will receive oral dydrogesterone, while the other half will receive oral placebo.
Age
18 - 45 years
Sex
FEMALE
Healthy Volunteers
Yes
Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand
Start Date
August 1, 2021
Primary Completion Date
August 31, 2022
Completion Date
August 31, 2022
Last Updated
August 30, 2023
100
ACTUAL participants
Dydrogesterone
DRUG
Placebo
DRUG
Lead Sponsor
Chulalongkorn University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions